GCT Announces New Office in Mumbai, India

GCT local office in Mumbai operating under the name “GCT Pharma Research (India) Pvt Ltd” (GCT-India for short) will assist global pharmaceutical companies in performing clinical trials in India. GCT-India will also support the local biopharma community willing to conduct clinical research within CEE countries and Russia, thus helping them to market their products in that attractive region.

GCT has appointed Dr. Umakanta Sahoo as Managing Director to set up the Indian entity and take charge of the local operations. Dr Sahoo, an MBA and PhD, brings extensive experience from the pharmaceutical and CRO industries in Asia Pacific. He has worked in global CROs handling projects for international pharmaceutical companies in a wide variety of therapeutic areas and has successfully run CRO business in India, Singapore, Taiwan, Australia and other SE Asian countries. His last assignment was in Singapore managing trials in SE Asian regions.

Welcoming Dr Sahoo, Eugene Selivra, Chief Executive Officer of GCT said:

We are delighted to partner with Dr Sahoo who will lead our team and services in the Asia-Pacific region, starting with India. This is part of GCT’s strategy to meet the growing needs of our clients to expand their reach to the Asian patient pool. This would also enable GCT to expand its services to data centric and analytics solutions where India is perceived to be very strong.

The geographic expansion to India is a next step in corporate development for GCT, after having already established strong presence in CEE region, with the latest of the new offices set up earlier this year in Warsaw, Poland.

GCT provides clinical research services to the international pharmaceutical, biotechnology and medical device industries, including clinical monitoring, project management, data management, biostatistics, medical writing, quality assurance, regulatory affairs, medical affairs, GCP & FDA compliant warehousing services. GCT has offices in USA, Central and Eastern EU countries, Ukraine, Russia, and now in India.

Need support for clinical trials in India?